Julie Faugeroux Selected Research

Antihypertensive Agents (Antihypertensives)

1/2022

Comparative therapeutic strategies for preventing aortic rupture in a mouse model of vascular Ehlers-Danlos syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Faugeroux Research Topics

Disease

2	Aortic Rupture 01/2022 - 07/2013
2	Type IV Ehlers-Danlos Syndrome 01/2022 - 07/2013
2	Hypertension (High Blood Pressure) 07/2013 - 01/2012
1	Lower Urinary Tract Symptoms 08/2020
1	Hyperplasia 08/2020
1	Hypertrophy 08/2020
1	Thoracic Aorta Dissection 07/2013
1	Rupture 07/2013
1	Hereditary Sensory and Autonomic Neuropathies (HSAN) 01/2012

Drug/Important Bio-Agent (IBA)

2	Collagen Type III (Type III Collagen)IBA 01/2022 - 07/2013
2	Angiotensin IIIBA 01/2022 - 07/2013
2	CollagenIBA 01/2022 - 07/2013
1	Losartan (Cozaar)FDA LinkGeneric 01/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2022
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Testosterone (Sustanon)FDA Link 08/2020
1	silodosin FDA Link 08/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2012
1	Lysine (L-Lysine)FDA Link 01/2012

Therapy/Procedure

1	Therapeutics 01/2022